Sign in

CIK 0001395937

  • Large accelerated filer

Syndax Pharmaceuticals Inc

Sign in to watch
Ticker
SNDX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
320162505
Phone
+1 781-419-1400
Business address
730 THIRD AVENUE, 9TH FLOOR, NEW YORK, NY, 10017
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$113,716
in 1 filing, $114K under 10b5-1 plans

Net −$113,716. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Podlesak Dennis −$114K Director sold 3% of stake
Date Insider Transaction Shares Price Value Owned after
2016-03-08 DP VI Associates, L.P. Director Conversion · Series A-1 Preferred Stock −13,925 0
2016-03-08 Domain Partners VI, L.P. 10% owner Conversion +1,743,854 1,743,854
2016-03-08 Domain Partners VI, L.P. 10% owner Conversion · Series A-1 Preferred Stock −1,299,394 0
2016-03-08 Domain Partners VI, L.P. 10% owner Conversion · Series B-1 Preferred Stock −444,460 0
2016-03-08 DP VIII Associates, L.P. 10% owner Conversion +5,641 5,641
2016-03-08 DP VIII Associates, L.P. 10% owner Conversion · Series B-1 Preferred Stock −2,967 0
2016-03-08 DP VIII Associates, L.P. 10% owner Conversion · Series C-1 Preferred Stock −2,674 0
2016-03-08 Domain Partners VIII, L.P. 10% owner Conversion +761,062 761,062
2016-03-08 Domain Partners VIII, L.P. 10% owner Conversion · Series B-1 Preferred Stock −400,422 0
2016-03-08 Domain Partners VIII, L.P. 10% owner Conversion · Series C-1 Preferred Stock −360,640 0

Page 28 of 28 · 550 trades